Search results
Moderna Shares Jump After Better-Than-Expected Sales
The Wall Street Journal· 13 hours agoModerna shares shot up about 7% Thursday after reporting better-than-expected quarterly sales and signaling confidence in a sales pickup later this year....
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 16 hours agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 11 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
NBC Philadelphia· 17 hours agoModerna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 12 hours agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...clinical programs and I will close by sharing our 2024...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 17 hours agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna posts quarterly sales beat, smaller loss than expected
Reuters via Yahoo Finance· 17 hours ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 21 hours agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...
Moderna Stock Rises on Vaccine Launch Target, Above-Consensus 1Q
Market Watch· 14 hours agoBy Dean Seal Shares of Moderna rose after the company set a fall target date for the launch of its next vaccine and posted better first-quarter results than...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 10 hours agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.